Anti-infectives in oncology
Oncology-related infections
Not specifiedPipeline candidate
Key Facts
Indication
Oncology-related infections
Phase
Not specified
Status
Pipeline candidate
Company
About Citius Pharmaceuticals
Citius Pharmaceuticals is a publicly traded, late-stage biopharma company focused on addressing unmet needs in critical care and oncology. The company has built a diversified pipeline with three main candidates, including the recently FDA-approved LYMPHIR™. With significant founder investment and a focus on products with large market potential, Citius aims to bring novel therapies to market faster.
View full company profile